FDA wants to use more real-world data and calls again for early-phase trials reform

The FDA will consider more real-world data in drug and device applications, including from large datasets that don’t have identifiable patient data, Commissioner Marty Makary told a Wall Street audience on Monday in New York …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registeration number 16808844